A prospective, randomized, double-blind, multicenter clinical study of Neiyifang in the treatment of congealing cold blood stasis of endometriosis

Shanghai Changhai Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? All cases should meet EM clinical diagnostic criteria and TCM diagnostic criteria of congealing cold blood stasis syndrome;
•? 18-40 years old;
•? Menstrual cycle between 21 and 35 days, period of 3 to 7 days;
•(4) VAS score =3, and pain must be continuous or recurrent for at least 6 months;
•? Those who voluntarily participated in the experiment and signed the informed consent;
•? Those who have not been treated with Western medicine or have been treated with western medicine but have stopped taking medicine for 3 months.

•1) patients with adenomyosis;
•2) Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney, diabetes and tumor;
•3) Mental illness and long-term alcohol or drug use affect cognition;
•4) Patients with chronic pelvic pain caused by anxiety and depression (depression scale and anxiety scale =50 points). (Less than 50 on the SELF-rated Anxiety scale/Self-rated Depression scale was considered normal; A score of 50-60 was mild anxiety; A score of 61 to 70 indicates moderate anxiety, while a score of 70 or more indicates severe anxiety.)
•5) Long-term use of painkillers or overuse of painkillers (more than 10 days in a month);
•6) Suspected or confirmed history of smoking, alcohol and drug abuse;
•7) Women who have positive pregnancy test, are pregnant or breast-feeding, or plan to have a pregnancy;
•8) allergic constitution and known allergic to the composition of the drug;
•9) Participants in other clinical trials or participants in clinical trials within 3 months prior to screening;
•10) Patients with coagulation dysfunction and previous thrombotic diseases;
•11) Those who are considered unsuitable for the clinical trial by the investigator.

发起方